Quest Diagnostics Inc.

DGX-N

NYSE:DGX

105.20
0.12 (0.11%)
Quest Diagnostics Incorporated is a Fortune 500 American company providing clinical laboratory services with headquarters in Secaucus, New Jersey.
More at Wikipedia

Analysis and Opinions about DGX-N

Signal
Opinion
Expert
WATCH
WATCH
May 3, 2019
Management couldn't give visibility into the business, so he sold it. Dominant national player. Have an opportunity to make further acquisitions. Will reassess this summer.
Management couldn't give visibility into the business, so he sold it. Dominant national player. Have an opportunity to make further acquisitions. Will reassess this summer.
Paul MacDonald
Chief Investment Officer & Portfolio Manager, Harvest Portfolios Group
Price
$99.075
Owned
No
TOP PICK
TOP PICK
June 17, 2011
Diagnostic laboratory. Trades at about 7X cash flow. 9.4% free cash flow yield. Good leverage to the economy. Do about 5,000 patient tests daily. Clinics are nation wide and reach about 50% of doctors and hospitals..
Diagnostic laboratory. Trades at about 7X cash flow. 9.4% free cash flow yield. Good leverage to the economy. Do about 5,000 patient tests daily. Clinics are nation wide and reach about 50% of doctors and hospitals..
Michael Simpson, CFA
Senior Vice-President, Sentry Investments
Price
$60.560
Owned
Yes
BUY
BUY
July 26, 2007
A leading laboratory and diagnostic business. Less susceptible to changes that could occur in the health sector in the US. Very profitable with a lot of free cash flow. Very defensive.
A leading laboratory and diagnostic business. Less susceptible to changes that could occur in the health sector in the US. Very profitable with a lot of free cash flow. Very defensive.
Jonathen Wellum, B. Comm, B. Sc
Chief Executive Officer, AIC Limited
Price
$55.870
Owned
Yes
TOP PICK
TOP PICK
February 9, 2007
Laboratory testing. The leader in the United States. Fits in well with demographics and growth in diagnostic testing. Recently lost a contract with United Health, which took the stock down 20%. Good price. Great long-term position.
Laboratory testing. The leader in the United States. Fits in well with demographics and growth in diagnostic testing. Recently lost a contract with United Health, which took the stock down 20%. Good price. Great long-term position.
Jonathen Wellum, B. Comm, B. Sc
Chief Executive Officer, AIC Limited
Price
$52.190
Owned
Yes
PAST TOP PICK
PAST TOP PICK
November 14, 2005
(A Top Pick Aug 31/05. Down 1.5%.) Took a big drop in October and bought more. A fabulous cash flow machine. A good long term holding.
(A Top Pick Aug 31/05. Down 1.5%.) Took a big drop in October and bought more. A fabulous cash flow machine. A good long term holding.
Brad Willock
Vice President and Senior Portfolio Manager, RBC Asset Management
Price
$48.210
Owned
Yes
TOP PICK
TOP PICK
August 31, 2005
The biggest medical lab in the US. Likes the demographic play. A fixed asset base and the revenue just comes out and churns into profits. A free cash flow machine. At about 15.5 X earnings.
The biggest medical lab in the US. Likes the demographic play. A fixed asset base and the revenue just comes out and churns into profits. A free cash flow machine. At about 15.5 X earnings.
Brad Willock
Vice President and Senior Portfolio Manager, RBC Asset Management
Price
$49.980
Owned
Yes
Showing 1 to 6 of 6 entries
  • «
  • 1
  • »